RenovoRx Statistics

Total Valuation

RenovoRx has a market cap or net worth of $35.25 million. The enterprise value is $26.00 million.

Market Cap	35.25M
Enterprise Value	26.00M

Important Dates

The next estimated earnings date is Friday, May 9, 2025, before market open.

Earnings Date	May 9, 2025
Ex-Dividend Date	n/a

Share Statistics

RenovoRx has 35.57 million shares outstanding. The number of shares has increased by 88.79% in one year.

Current Share Class	35.57M
Shares Outstanding	35.57M
Shares Change (YoY)	+88.79%
Shares Change (QoQ)	+3.71%
Owned by Insiders (%)	1.28%
Owned by Institutions (%)	2.85%
Float	35.11M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	3.39
P/TBV Ratio	5.03
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 5.66

Current Ratio	5.66
Quick Ratio	5.40
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -258.95% and return on invested capital (ROIC) is -178.66%.

Return on Equity (ROE)	-258.95%
Return on Assets (ROA)	-93.31%
Return on Invested Capital (ROIC)	-178.66%
Return on Capital Employed (ROCE)	-122.47%
Revenue Per Employee	n/a
Profits Per Employee	-$1.15M
Employee Count	8
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -27.54% in the last 52 weeks. The beta is 1.15, so RenovoRx's price volatility has been higher than the market average.

Beta (5Y)	1.15
52-Week Price Change	-27.54%
50-Day Moving Average	1.13
200-Day Moving Average	1.14
Relative Strength Index (RSI)	46.54
Average Volume (20 Days)	73,140

Short Selling Information

The latest short interest is 189,155, so 0.53% of the outstanding shares have been sold short.

Short Interest	189,155
Short Previous Month	235,192
Short % of Shares Out	0.53%
Short % of Float	0.54%
Short Ratio (days to cover)	1.95

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-10.12M
Pretax Income	-8.05M
Net Income	-9.16M
EBITDA	n/a
EBIT	-10.12M
Earnings Per Share (EPS)	-$0.49

Full Income Statement

Balance Sheet

The company has $9.56 million in cash and n/a in debt, giving a net cash position of $9.56 million or $0.27 per share.

Cash & Cash Equivalents	9.56M
Total Debt	n/a
Net Cash	9.56M
Net Cash Per Share	$0.27
Equity (Book Value)	7.07M
Book Value Per Share	0.29
Working Capital	8.26M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-8.75M
Capital Expenditures	n/a
Free Cash Flow	-8.75M
FCF Per Share	-$0.25

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

RenovoRx does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-88.79%
Shareholder Yield	n/a
Earnings Yield	-25.76%
FCF Yield	-24.60%

Analyst Forecast

The average price target for RenovoRx is $6.00, which is 505.33% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$6.00
Price Target Difference	505.33%
Analyst Consensus	Strong Buy
Analyst Count	2
Revenue Growth Forecast (5Y)	11.46%
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2